3D bio-printing technology
At present, iPSC for 3D bio-printing technology is mainly used in drug testing, through the cultivation of organ-on-a-chip to test the effectiveness and toxicity of drugs. Due to the complex functions of human organs, many drugs showed significant efficacy in animals but failed in clinical trials since organs in the human body may accidentally digest, swallow, or even degrade the medicine. A very meaningful technology is called "human-on-a-chip" to integrate human tissue into a microfluidic device to simulate human blood runoff from various organs. This technology not only avoids animal experiments and human experiments that are ethically controversial, and saves the cost of clinical trials, but it can also better eliminate drug toxicity and find more effective drugs or treatment strategies to truly benefit patients.
|
No arguments found. Add one!
|
